Protagonist Therapeutics Inc (PTGX)
R&D to Revenue
346.16%
Fiscal year · Period ending:
PTGX R&D to Revenue
Latest reported346.16%period ending
Latest reported346.16%period ending
PTGX FY R&D/Revenue (0.00% → 346.16%)
Latest values, visible window
High-resolution chart · PNG
PTGX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 346.1622% | |
| 31.795% | |
| 200.2683% | |
| 474.8316% | |
| 460.5987% | |
| 265.4185% | |
| 28,139.8268% | |
| 192.3913% | |
| 230.1799% | |
| 0% | |
| 0% | |
| 0% |